Human Papillomavirus Selected Properties and Related Cervical Cancer Prevention Issues

被引:6
作者
Balmagambetova, Saule [1 ]
Tinelli, Andrea [2 ,3 ]
Mynbaev, Ospan A. [3 ,4 ]
Koyshybaev, Arip [1 ]
Urazayev, Olzhas [1 ]
Kereyeva, Nurgul [1 ]
Ismagulova, Elnara [5 ]
机构
[1] West Kazakhstan Marat Ospanov Med Univ, Dept Oncol, Aktobe 030012, Kazakhstan
[2] Vito Fazzi Hosp, Div Expt Endoscop Surg Imaging Technol & Minimall, Piazza Muratore, Lecce, Italy
[3] State Univ, Lab Human Physiol, Phystech BioMed Sch, Fac Biol & Med Phys,Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia
[4] Pirogov Russian Natl Res Med Univ, Moscow, Russia
[5] West Kazakhstan Marat Ospanov Med Univ, Maresyev St, Aktobe 030012, Kazakhstan
关键词
Human papillomavirus; cervical cancer; screening; vaccination; incidence; Kazakhstan; IN-SITU HYBRIDIZATION; LIQUID-BASED CYTOLOGY; GENETIC-VARIATION; HPV VACCINATION; P16; IMMUNOHISTOCHEMISTRY; SECONDARY PREVENTION; MOLECULAR-MECHANISMS; PAP-SMEARS; VIRAL LOAD; FOLLOW-UP;
D O I
10.2174/1381612826666200422094205
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
High-risk human papillomavirus strains are widely known to be the causative agents responsible for cervical cancer development. Aggregated damage caused by papillomaviruses solely is estimated in at least 5% of all malignancies of the human body and 16% in cancers that affect the female genital area. Enhanced understanding of the complex issue on how the high extent of carcinogenicity is eventually formed due to the infection by the Papoviridae family would contribute to enhancing current prevention strategies not only towards cervical cancer, but also other HPV associated cancers. This review article is aimed at presenting the key points in two directions: the current cervical cancer prevention and related aspects of HPV behavior. Virtually all applied technologies related to HPV diagnostics and screening programs, such as HPV tests, colposcopy-based tests (VIA/VILI), conventional and liquid-based cytology, currently available are presented. Issues of availability, advantages, and drawbacks of the screening programs, as well as vaccination strategies, are also reviewed in the article based on the analyzed sources. The current point of view regarding HPV is discussed with emphasis on the most problematic aspect of the HPV family concerning the observed increasing number of highly carcinogenic types. Present trends in HPV infection diagnostics throughout the human fluids and tissues are also reported, including the latest novelties in this field, such as HPV assay/self-sample device combinations. Besides, a brief outline of the related prevention issues in Kazakhstan, the leading country of Central Asia, is presented. Kazakhstan, as one of the post-soviet middle-income countries, may serve as an example of the current situation in those terrains, concerning the implementation of globally accepted cervical cancer prevention strategies. Along with positive achievements, such as the development of a nationwide screening program, a range of drawbacks is also analyzed and discussed.
引用
收藏
页码:2073 / 2086
页数:14
相关论文
共 50 条
  • [1] The potential of urine for human papillomavirus-related cervical cancer prevention
    Lamsisi, Maryame
    Li, Guorong
    Chauleur, Celine
    Ennaji, Moulay Mustapha
    Bourlet, Thomas
    FUTURE VIROLOGY, 2022, 17 (07) : 495 - 508
  • [2] Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts
    Sahasrabuddhe, Vikrant V.
    Luhn, Patricia
    Wentzensen, Nicolas
    FUTURE MICROBIOLOGY, 2011, 6 (09) : 1083 - 1098
  • [3] Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges
    Poljak, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 : 64 - 69
  • [4] Prevention of Cervical Cancer with Human Papillomavirus Vaccines
    Alabaz, Derya
    Aksaray, Necmi
    JOURNAL OF PEDIATRIC INFECTION, 2007, 1 (04): : 147 - 150
  • [5] Human Papillomavirus Testing in the Prevention of Cervical Cancer
    Schiffman, Mark
    Wentzensen, Nicolas
    Wacholder, Sholom
    Kinney, Walter
    Gage, Julia C.
    Castle, Philip E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (05): : 368 - 383
  • [6] Cervical cancer prevention and screening: the role of human papillomavirus testing
    Aref-Adib, Mehrnoosh
    Freeman-Wang, Theresa
    OBSTETRICIAN & GYNAECOLOGIST, 2016, 18 (04) : 251 - 263
  • [7] Advances in prevention of cervical cancer and other human papillomavirus-related diseases
    Frazer, IH
    Cox, JT
    Mayeaux, EJ
    Franco, EL
    Moscicki, AB
    Palefsky, JM
    Ferris, DG
    Ferenczy, AS
    Villa, LL
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (02) : S65 - S81
  • [8] Human Papillomavirus, Current Vaccines, and Cervical Cancer Prevention
    Teitelman, Anne M.
    Stringer, Marilyn
    Averbuch, Tali
    Witkoski, Amy
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2009, 38 (01): : 69 - 80
  • [9] Integrating Human Papillomavirus Vaccination in Cervical Cancer Control Programmes
    Franco, Eduardo L.
    Coutlee, Francois
    Ferenczy, Alex
    PUBLIC HEALTH GENOMICS, 2009, 12 (5-6) : 352 - 361
  • [10] Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer
    Garland, Suzanne M.
    Brown, Darron R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (04) : 527 - 534